In vitro fertilization stimulation protocol for normal responder patients

By Marci R.   Caserta D.   Lisi F.   Graziano A.   Soave I.   Lo Monte G.   Patella A.   Moscarini M.  

Gynecological Endocrinology, Vol. 29, Iss. 2, 2013-02 ,pp. : 109-112

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration

By Friedler S.   Raziel A.   Schachter M.   Strassburger D.   Bukovsky I.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1944-1948

Oxford University Press

Access to resources Recommend Favorite

Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization

By Alvarez C.   Cremades N.   Blasco N.   Bernabeu R.  

Human Reproduction, Vol. 12, Iss. 11, 1997-11 ,pp. : 2366-2369

Oxford University Press

Access to resources Recommend Favorite

Endocrinology: Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone

By Pouly Jean Luc  

Human Reproduction, Vol. 11, Iss. 10, 1996-10 ,pp. : 2085-2089

Oxford University Press

Access to resources Recommend Favorite

Uterine glandular area during the menstrual cycle and the effects of different in-vitro fertilization related hormonal treatments

By Rogers P.A.W  

Human Reproduction, Vol. 11, Iss. 2, 1996-02 ,pp. : 376-379

Oxford University Press

Access to resources Recommend Favorite